Skip to main content

Table 1 Incidence of adverse events (AEs), adverse reactions and serious AEs (SAEs) for the two vaccine groups

From: Safety and immunogenicity of an MF59™-adjuvanted subunit influenza vaccine in elderly Chinese subjects

 

Incidence, %(n)

P-value

 

Sub/MF59™ (n = 391)

Subunit (n = 198)

 

Local reactions

24.0(94)

15.2(30)

0.012

Systemic reactions

10.7(42)

9.6(19)

0.666

AEs

6.1(24)

6.6(13)

0.840

SAEs

1.0(4)

0.5(1)

0.668

Vaccine-related AEs (definitely, probably or possibly related to the vaccine)

3.8(15)

5.1(10)

0.490

Vaccine-related SAEs (definitely, probably or possibly related to the vaccine)

0.3(1)

0.0(0)

1.000

  1. Sub/MF59™, MF59™-adjuvanted subunit influenza vaccine; Subunit, non-adjuvanted subunit influenza vaccine